Stock Ratings from Analyst Ratings Network

Open Main Menu Open Sidebar

Sangamo Biosciences Company Profile (NASDAQ:SGMO)

Consensus Ratings for Sangamo Biosciences (NASDAQ:SGMO) (?)
Ratings Breakdown: 1 Sell Rating(s), 1 Hold Rating(s), 3 Buy Rating(s)
Consensus Rating:Hold (Score: 2.40)
Consensus Price Target: $23.15 (57.91% upside)

Analysts' Ratings History for Sangamo Biosciences (NASDAQ:SGMO)
Show:
DateFirmActionRatingPrice TargetDetailsShare
3/17/2014ZacksUpgradeUnderperform -> Neutral$23.60ViewTweet This Rating  Share This Rating on StockTwits
3/12/2014JMP SecuritiesBoost Price TargetOutperform$22.00 -> $27.00ViewTweet This Rating  Share This Rating on StockTwits
1/9/2014WedbushBoost Price Target$22.00ViewTweet This Rating  Share This Rating on StockTwits
11/5/2013WedbushBoost Price TargetOutperform$13.00 -> $15.00ViewTweet This Rating  Share This Rating on StockTwits
10/23/2013Lazard Capital MarketsBoost Price TargetBuy$16.00 -> $20.00ViewTweet This Rating  Share This Rating on StockTwits
7/30/2013ZacksUpgradeNeutral -> Outperform$10.50ViewTweet This Rating  Share This Rating on StockTwits
6/17/2013Cowen and CompanyReiterated RatingOutperformViewTweet This Rating  Share This Rating on StockTwits
5/3/2013BioLogic Equity ResearchInitiated CoverageSellViewTweet This Rating  Share This Rating on StockTwits
3/28/2013JMP SecuritiesInitiated CoverageOutperform$16.00ViewTweet This Rating  Share This Rating on StockTwits
3/7/2013WedbushBoost Price TargetOutperform$10.00 -> $13.00ViewTweet This Rating  Share This Rating on StockTwits
2/28/2013Lazard Ltd.Initiated CoverageBuy$16.00ViewTweet This Rating  Share This Rating on StockTwits
2/19/2013Burrill Institutional ResearchInitiated CoverageOutperform$28.00ViewTweet This Rating  Share This Rating on StockTwits
1/3/2013Piper JaffrayUpgradeUnderweight -> OverweightViewTweet This Rating  Share This Rating on StockTwits
7/2/2012Piper JaffrayDowngradeNeutral -> UnderweightViewTweet This Rating  Share This Rating on StockTwits
(Data available from 4/23/2012 forward)